Investors beware: Cowealth Medical China remains loss‑making, its 61% spike is driven by speculation, not fundamentals, and a quick correction is likely.

Discover why Cowealth Medical China’s Q1 earnings miss sparked a 46.5% stock rally amid market‑wide health‑tech momentum and AI‑driven growth prospects.